COVID-19 study for vaccinated and unvaccinated persons over 16

• Conditions: U07.2; COVID-19, virus not identified

• Registration Number: DRKS00025169
• Lead Sponsor: Data4Life gGmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-08-13
• Study Completion: 2022-08-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 755

Inclusion Criteria

All participants with a minimum age of 18 years who agree to participate in the study and can successfully register in the web-based study app are eligible to participate.

Exclusion Criteria

No internet access.
Not proficient in German or English.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effectiveness of SARS-CoV-2 vaccines against laboratory-confirmed (PCR or rapid test) SARS-CoV-2 infection, regardless of any presenting symptomatology.

Secondary Outcome Measures

Name	Time	Method
Effectiveness of SARS-CoV-2 vaccines against<br>- a symptomatic, COVID-19-type illness.<br>- a symptomatic, laboratory-confirmed SARS-CoV-2 infection. (PCR or rapid smear)<br>- against a severe SARS-CoV-2 infection (as defined by the Seeking medical attention).<br>Occurrence of any adverse reactions possibly associated with the SARS-CoV-2 vaccines. associated side effects.